Recent changes

Jump to: navigation, search

Track the most recent changes to the wiki on this page.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 01:04, 16 May 2021
   

15 May 2021

     21:18  Peripheral T-cell lymphoma‎ (diff | hist) . . (+2). . Warner-admin (talk | contribs)
     21:18  Pancreatic cancer‎‎ (5 changes | history) . . (-3,431). . [Warner-admin‎; Jwarner‎ (4×)]
      21:18 (cur | prev) . . (+1). . Warner-admin (talk | contribs)
 m    09:48 (cur | prev) . . (+30). . Jwarner (talk | contribs) (Gemcitabine monotherapy {{#subobject:4f0be9|Regimen=1}})
 m    09:47 (cur | prev) . . (-1,598). . Jwarner (talk | contribs) (FLEC {{#subobject:a6c123|Regimen=1}})
 m    09:46 (cur | prev) . . (+30). . Jwarner (talk | contribs) (Regimen variant #2, 1000 mg/m2, 8-week lead-in ("Burris regimen") {{#subobject:5d6dd0|Variant=1}})
 m    09:45 (cur | prev) . . (-1,894). . Jwarner (talk | contribs) (PEFG {{#subobject:f0e123|Regimen=1}})
     21:17  Chronic lymphocytic leukemia‎‎ (2 changes | history) . . (+16). . [Warner-admin‎ (2×)]
      21:17 (cur | prev) . . (+1). . Warner-admin (talk | contribs)
 m    12:05 (cur | prev) . . (+15). . Warner-admin (talk | contribs) (Text replacement - "IV continuous infusion on days 1 to 7" to "IV continuous infusion over 7 days, started on day 1") (Tags: Mobile edit, Mobile web edit)
     21:04  Multiple myeloma, consolidation and maintenance‎‎ (4 changes | history) . . (+33). . [Jwarner‎; Warner-admin‎ (3×)]
      21:04 (cur | prev) . . (+5). . Warner-admin (talk | contribs) (Targeted therapy)
 m    21:04 (cur | prev) . . (+5). . Warner-admin (talk | contribs) (Targeted therapy, maintenance)
 m    14:27 (cur | prev) . . (+16). . Jwarner (talk | contribs)
      08:24 (cur | prev) . . (+7). . Warner-admin (talk | contribs) (Bortezomib monotherapy {{#subobject:dd778e|Regimen=1}})
 m   14:28  Multiple myeloma - historical‎ (diff | hist) . . (+15). . Jwarner (talk | contribs) (Regimen variant #5, 0.4/9/40 (bolus doxorubicin & vincristine, dex 12 days/cycle in cycles 1-3) {{#subobject:20136a|Variant=1}})
 m   14:27  Multiple myeloma, induction‎ (diff | hist) . . (+68). . Jwarner (talk | contribs)
 m   14:25  Burkitt lymphoma‎‎ (2 changes | history) . . (-8). . [Warner-admin‎; Jwarner‎]
 m    14:25 (cur | prev) . . (-4). . Jwarner (talk | contribs) (Untreated)
 m    08:09 (cur | prev) . . (-4). . Warner-admin (talk | contribs) (Text replacement - "(160/800 mg)" to "160/800 mg") (Tags: Mobile edit, Mobile web edit)
     12:36  Langerhans cell histiocytosis‎ (diff | hist) . . (+24). . Warner-admin (talk | contribs)
     12:36  Gastric cancer‎‎ (2 changes | history) . . (+106). . [Warner-admin‎ (2×)]
      12:36 (cur | prev) . . (+88). . Warner-admin (talk | contribs)
      12:33 (cur | prev) . . (+18). . Warner-admin (talk | contribs)
 m   12:34  Breast cancer, HER2-positive‎ (diff | hist) . . (+22). . Warner-admin (talk | contribs)
     12:31  Colon cancer‎‎ (2 changes | history) . . (+48). . [Warner-admin‎ (2×)]
      12:31 (cur | prev) . . (+48). . Warner-admin (talk | contribs) (Chemotherapy)
      12:14 (cur | prev) . . (0). . Warner-admin (talk | contribs)
     12:29  Melanoma‎‎ (2 changes | history) . . (+105). . [Warner-admin‎ (2×)]
      12:29 (cur | prev) . . (+121). . Warner-admin (talk | contribs) (IL-2 monotherapy {{#subobject:fa72a9|Regimen=1}})
 m    12:20 (cur | prev) . . (-16). . Warner-admin (talk | contribs) (Immunotherapy, pulse cycles (2, 3, 5, 6, 8, 10, 12))
     12:16  Ovarian cancer‎ (diff | hist) . . (+4). . Warner-admin (talk | contribs)
     12:14  Head and neck cancer‎ (diff | hist) . . (0). . Warner-admin (talk | contribs)
     12:13  Anal cancer‎ (diff | hist) . . (+33). . Warner-admin (talk | contribs)
 m   12:12  Esophageal adenocarcinoma‎ (diff | hist) . . (-4). . Warner-admin (talk | contribs) (Text replacement - "m<sup>2</sup> )" to "m<sup>2</sup>)")
 m   12:11  Esophageal cancer‎ (diff | hist) . . (-1). . Warner-admin (talk | contribs) (Text replacement - "m<sup>2</sup> )" to "m<sup>2</sup>)")
 m   12:11  Esophageal squamous cell carcinoma‎ (diff | hist) . . (-3). . Warner-admin (talk | contribs) (Text replacement - "m<sup>2</sup> )" to "m<sup>2</sup>)")
     12:08  Penile cancer‎ (diff | hist) . . (-14). . Warner-admin (talk | contribs) (PCF {{#subobject:edc2a7|Regimen=1}})
 m   12:04  Editing test page‎ (diff | hist) . . (+15). . Warner-admin (talk | contribs) (Text replacement - "IV continuous infusion on days 1 to 7" to "IV continuous infusion over 7 days, started on day 1")
 m   12:04  Acute myeloid leukemia, FLT3-positive‎ (diff | hist) . . (+30). . Warner-admin (talk | contribs) (Text replacement - "IV continuous infusion on days 1 to 7" to "IV continuous infusion over 7 days, started on day 1") (Tags: Mobile edit, Mobile web edit)
 m   11:50  Drug index‎ (diff | hist) . . (+11). . Jwarner (talk | contribs) (Interesting and Helpful Links)
 m   11:49  Tutorial‎ (diff | hist) . . (-94). . Jwarner (talk | contribs) (Interesting and helpful links)
 m   09:57  Iptacopan (LNP023)‎‎ (2 changes | history) . . (+179). . [Jwarner‎ (2×)]
 m    09:57 (cur | prev) . . (+61). . Jwarner (talk | contribs)
 m    09:51 (cur | prev) . . (+118). . Jwarner (talk | contribs)
 m   09:47  Pancreatic cancer - historical‎‎ (2 changes | history) . . (+3,622). . [Jwarner‎ (2×)]
 m    09:47 (cur | prev) . . (+1,678). . Jwarner (talk | contribs) (Metastatic disease, first-line)
 m    09:45 (cur | prev) . . (+1,944). . Jwarner (talk | contribs) (Metastatic disease, all lines of therapy)
 m   09:42  Paroxysmal nocturnal hemoglobinuria‎ (diff | hist) . . (+27). . Jwarner (talk | contribs) (Investigational agents)
 m   09:03  Bladder cancer‎ (diff | hist) . . (-4). . Warner-admin (talk | contribs) (Text replacement - "IV or oral equivalent" to "IV or PO equivalent") (Tags: Mobile edit, Mobile web edit)
 m   08:11  Hodgkin lymphoma‎ (diff | hist) . . (-2). . Warner-admin (talk | contribs) (Text replacement - "(160/800 mg)" to "160/800 mg")
 m   08:10  HIV-associated lymphoma‎ (diff | hist) . . (-2). . Warner-admin (talk | contribs) (Text replacement - "(160/800 mg)" to "160/800 mg")
 m   08:10  Hodgkin lymphoma, nodular lymphocyte-predominant‎ (diff | hist) . . (-8). . Warner-admin (talk | contribs) (Text replacement - "(160/800 mg)" to "160/800 mg")
 m   08:09  B-cell acute lymphoblastic leukemia‎ (diff | hist) . . (-8). . Warner-admin (talk | contribs) (Text replacement - "(160/800 mg)" to "160/800 mg")
 m   08:09  B-cell acute lymphoblastic leukemia, Ph-positive‎ (diff | hist) . . (-12). . Warner-admin (talk | contribs) (Text replacement - "(160/800 mg)" to "160/800 mg")
 m   08:09  Autologous HSCT‎ (diff | hist) . . (-2). . Warner-admin (talk | contribs) (Text replacement - "(160/800 mg)" to "160/800 mg") (Tags: Mobile edit, Mobile web edit)

14 May 2021

     17:09  Paroxysmal nocturnal hemoglobinuria‎‎ (2 changes | history) . . (+1,389). . [Karine‎ (2×)]
      17:09 (cur | prev) . . (+1,298). . Karine (talk | contribs) (iptacopan Lancet study regimen and reference)
 m    16:55 (cur | prev) . . (+91). . Karine (talk | contribs) (investigational agents for PNH) (Tag: Visual edit)
 m   16:48  Iptacopan (LNP023)‎ (diff | hist) . . (+330). . Karine (talk | contribs) (Iptacopan drug index info continued)